Home > Press > UT Southwestern develops nanotherapeutic to ward off liver cancer
The engineered nanoparticle encapsulates miR-122 in the core and targets hepatocytes using Gal (blue dots). it delivers the miR-122 into hepatocytes which make them “healthier.” CREDIT UT Southwestern Medical Center |
Abstract:
Physician researchers from UT Southwestern Medical Center have developed an innovative nanotherapeutic drug that prevents cancer from spreading to the liver in mice.
The new liver-specific microRNA drug, developed by a team led by Andrew Wang, M.D., is a promising candidate for drug companies that developed messenger RNA (mRNA) vaccines for COVID-19, because of similarities in these RNA agents.
“This might be one ray of hope that comes out of the pandemic,” said Dr. Wang, Professor, Radiation Oncology, and author of a rodent-based study published in the journal Cancer Research.
“It takes major funding and resources to develop nanoparticles that can deliver nucleic acids such as mRNA and miRNA. Before the development of COVID-19 vaccines, the cost was prohibitive. But now that several platforms have been developed and approved, these platforms/nanoparticles can be utilized for other applications such as what we developed in in mice models in my lab,” added Dr. Wang, Radiation Oncology’s Associate Vice Chair for Research, and member of the Harold C. Simmons Comprehensive Cancer Center.
The study drug’s core was made by complexing miR-122 with calcium phosphate, and lipids were wrapped around the core to make the nanoparticle. The drug delivers the miR-122 into hepatocytes, which make them “healthier” by helping prevent cancer cells from establishing themselves in the liver. Although the drug has only been tested in mice, it is a valued advance in the fight against cancer, as up to 70 percent of people with conditions like colorectal cancer eventually develop liver metastases.
“Liver metastases are second only to lung metastases, so new therapeutics in this area are an urgent need in oncology. Dr. Wang’s study is promising because it showed minimal toxicity,” said Carlos L. Arteaga, M.D., Director of the Harold C. Simmons Comprehensive Cancer Center, who holds The Lisa K. Simmons Distinguished Chair in Comprehensive Oncology.
Funding for the study and initial drug development was provided by National Cancer Institute/National Institutes of Health U54CA198999, NIH T32CA196589 and the University of North Carolina Research Opportunity Initiative.
####
About UT Southwestern Medical Center
UT Southwestern, one of the nation’s premier academic medical centers, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty has received six Nobel Prizes, and includes 25 members of the National Academy of Sciences, 16 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,800 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in about 80 specialties to more than 117,000 hospitalized patients, more than 360,000 emergency room cases, and oversee nearly 3 million outpatient visits a year.
For more information, please click here
Contacts:
UT Southwestern Medical Center
Office: 214-648-3404
Copyright © UT Southwestern Medical Center
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related Links |
Related News Press |
News and information
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Cancer
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Super-efficient laser light-induced detection of cancer cell-derived nanoparticles: Skipping ultracentrifugation, detection time reduced from hours to minutes! October 6th, 2023
Possible Futures
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
With VECSELs towards the quantum internet Fraunhofer: IAF achieves record output power with VECSEL for quantum frequency converters April 5th, 2024
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Discoveries
Chemical reactions can scramble quantum information as well as black holes April 5th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Utilizing palladium for addressing contact issues of buried oxide thin film transistors April 5th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Nanobiotechnology
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||